FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to medicinal agents containing combined inhibitor of dipeptidylpeptidase IV (DPPIV) and biguanide agent. Offered application of pharmaceutical agent implies production of preventive and therapeutic agent and method of intensified effects of active circulating GLP-1 and/or active circulating GLP-2. Besides, invention concerns method of prevention or treatment of disease connected with active circulating GLP-1 and/or active circulating GLP-2, specifically diabetes, obesity, hyperlipidemia, gastrointestinal diseases. Combined inhibitor DPPIV of formula (I) and biguanide agent, specifically phenformine, methformin or buformine stimulates action of active circulating glucagon-like peptide-1 (GLP-1) and/or active circulating glucagon-like peptide -2 (GLP-2) and, therefore inhibits destruction of GLP-1 and GLP-2, with their levels raised up with biguanide agent.
EFFECT: agent has improved efficiency.
17 cl, 12 tbl, 425 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL CONDENSED DERIVATIVES OF IMIDAZOLE, INHIBITORS OF DIPEPTIDYL PEPTIDASE IV, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND USING BASED ON THEREOF | 2003 |
|
RU2297418C9 |
COMPOUNDS WITH CONDENSED 1,3-DIHYDROIMIDAZOLE CYCLE | 2003 |
|
RU2328498C9 |
AMIDO-SUBSTITUTED DERIVATIVES OF XANTHINE POSSESSING INHIBITORY EFFECT ON ACTIVITY OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (PEPCK), METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION AND USING | 2003 |
|
RU2295525C2 |
CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS | 2008 |
|
RU2479584C2 |
HYDROXYPURINE COMPOUNDS AND USE THEREOF | 2016 |
|
RU2685417C1 |
NOVEL COMPOUNDS | 2005 |
|
RU2395511C2 |
THIENOPYRIMIDINE COMPOUNDS AND THEIR APPLICATION | 2004 |
|
RU2331648C2 |
MORPHOLINOPURINE DERIVATIVES, HAVING PI3K AND/OR mTOR INHIBITING ACTIVITY | 2009 |
|
RU2490269C2 |
NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED ON SAID AND METHOD OF TREATMENT OR PROPHYLAXIS OF THROMBOTIC DISEASES | 1995 |
|
RU2156763C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
Authors
Dates
2008-07-10—Published
2003-09-22—Filed